BHV-1490

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameBHV-1490
Drug Alias NameBHV-1490BHV1490
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionImmunoglobulin M degradersAsialoglycoprotein receptor binders
TargetsImmunoglobulin MAsialoglycoprotein receptor
Therapy Area/IndicationsPeripheral Nervous System DiseasesWaldenstrom Macroglobulinemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiohaven Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System DiseasesWaldenstrom Macroglobulinemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A